fibrinogen has been researched along with Hypertrophy, Left Ventricular in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 5 (21.74) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, Q; Liu, N; Liu, Z; Ma, M; Wang, J; Xing, Y; Zhang, Y; Zhu, L | 1 |
| Badeĭnikova, KK; Didigova, RT; Mamedov, MN; Mazaev, AP; Toguzova, ZA | 1 |
| Edison, ES; Hoshide, S; Kario, K; Yano, Y | 1 |
| Balakrishnannair, S; Banerjee, M; Cruickshank, JK; Herbert, A; Lawrance, JA; Paisley, AN; Rezai, M; Schofield, RE; Trainer, PJ | 1 |
| Micozkadıoğlu, H; Ozelsancak, R; Torun, D; Yiğit, F | 1 |
| Catena, C; Colussi, G; Sechi, LA; Valeri, M | 1 |
| Best, L; Celentano, A; de Simone, G; Devereux, RB; Fabsitz, RR; Howard, BV; Lewis, MR; Palmieri, V; Robbins, DC; Roman, MJ | 1 |
| Benedetto, FA; Bonanno, G; Buemi, M; Cutrupi, S; Fatuzzo, P; Malatino, LS; Mallamaci, F; Nicocia, G; Parlongo, S; Rapisarda, F; Seminara, G; Tripepi, G; Zoccali, C | 1 |
| Bella, JN; Best, LG; Devereux, RB; Howard, BV; Liu, JE; Palmieri, V; Robbins, DC; Roman, MJ; Tracy, RP | 1 |
| Cases, A | 1 |
| Aras, D; Ayaz, S; Balbay, OA; Balbay, Y; Bilgiç, F; Cağli, K; Cihan, G; Ergün, K; Korkmaz, S; Saşmaz, H | 1 |
| Kobus, G; Małyszko, J; Myśyliwiec, M | 1 |
| Ciechanowicz, A; Foltyńska-Nowakowska, A; Goracy, I; Jastrzebska, M; Naruszewicz, M; Torbus-Lisiecka, B; Wesołowska, T; Widecka, K | 1 |
| Chambless, LE; Folsom, AR; Mosley, TH; Ohira, T; Rosamond, WD; Shahar, E | 1 |
| Czarnecka, D; Jastrzebski, M; Kawecka-Jaszcz, K; Rajzer, M | 1 |
| Catapano, G; Di Bello, V; Ferrari, M; Giusti, C; Materazzi, F; Melillo, E; Mosca, F; Pedrinelli, R; Santoro, G; Talarico, L | 1 |
| Abramov, N; Blieden, LC; Gil-Ad, I; Goez, R; Kuberger, N; Laron, Z; Weizman, A | 1 |
| Beevers, DG; Blann, AD; Jones, AF; Lip, GY; Lip, PL | 1 |
| Beevers, DG; Cook, PJ; Davies, P; Honeybourne, D; Lip, GY; Wise, R | 1 |
| Harjai, KJ | 1 |
| Lip, GY; Spencer, CG | 1 |
| Kannel, WB | 1 |
| Best, L; Celentano, A; de Simone, G; Devereux, RB; Howard, BV; Lee, ET; Lewis, MR; Palmieri, V; Robbins, DC; Roman, MJ | 1 |
3 review(s) available for fibrinogen and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
[New cardiovascular risk factors and chronic kidney disease. Hypertrophy of the left ventricle. Atrial fibrillation. Smoking. Obesity. Emerging cardiovascular risk factors: homocysteine, Reactive C protein. Fibrinogen].
Topics: Atrial Fibrillation; C-Reactive Protein; Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Obesity; Risk Factors; Smoking | 2004 |
Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress, and fibrinogen.
Topics: Cardiovascular Diseases; Fibrinogen; Homocysteine; Humans; Hyperhomocysteinemia; Hypertriglyceridemia; Hypertrophy, Left Ventricular; Lipoprotein(a); Oxidative Stress; Risk Factors; Triglycerides | 1999 |
Influence of multiple risk factors on the hazard of hypertension.
Topics: Animals; Coronary Disease; Exercise; Fibrinogen; Glucose Intolerance; Humans; Hypertension; Hypertrophy, Left Ventricular; Lipoproteins; Risk Factors; Smoking | 1990 |
20 other study(ies) available for fibrinogen and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Elevated plasma macrophage migration inhibitor factor is associated with hypertension and hypertensive left ventricular hypertrophy.
Topics: Cell Movement; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Logistic Models; Macrophages | 2023 |
[Detection of early markers of atherosclerosis in men with various levels of risk of cardiovascular complications].
Topics: Adult; Ankle Brachial Index; Atherosclerosis; Biomarkers; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Early Diagnosis; Fibrinogen; Glucose; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Assessment; Risk Factors; Tomography, Spiral Computed; Ultrasonography, Doppler, Duplex; Uric Acid | 2014 |
Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
Topics: Age Factors; Aged; Aged, 80 and over; Asian People; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Electrocardiography; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Incidence; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Norepinephrine; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Factors | 2015 |
Changes in arterial stiffness but not carotid intimal thickness in acromegaly.
Topics: Acromegaly; Adult; Aged; Arteries; Blood Glucose; Blood Pressure; Body Mass Index; C-Reactive Protein; Carotid Arteries; Cross-Sectional Studies; Female; Fibrinogen; Glycated Hemoglobin; Humans; Hypertrophy, Left Ventricular; Insulin; Insulin-Like Growth Factor I; Lipids; Male; Middle Aged; Regression Analysis; Supine Position; Ultrasonography | 2011 |
Increased inflammatory markers are associated with obesity and not with target organ damage in newly diagnosed untreated essential hypertensive patients.
Topics: Adult; Aged; Albuminuria; Body Mass Index; C-Reactive Protein; Case-Control Studies; Cross-Sectional Studies; Female; Fibrinogen; Homocysteine; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation Mediators; Male; Middle Aged; Obesity; Risk Factors | 2012 |
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels.
Topics: Adult; Aged; Aldosterone; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Renin-Angiotensin System | 2013 |
Relation of fibrinogen to cardiovascular events is independent of preclinical cardiovascular disease: the Strong Heart Study.
Topics: Cardiovascular Diseases; Echocardiography; Fibrinogen; Heart Diseases; Humans; Hypertrophy, Left Ventricular; Indians, North American; Longitudinal Studies; Risk Factors; Ventricular Dysfunction, Left | 2003 |
Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure.
Topics: Blood Pressure; Echocardiography; Female; Fibrinogen; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Male; Middle Aged; Ventricular Dysfunction, Left | 2003 |
Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study.
Topics: Aged; Albuminuria; Arteriosclerosis; Biomarkers; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Fibrinogen; Humans; Hypertrophy, Left Ventricular; Incidence; Indians, North American; Inflammation; Male; Middle Aged; Prevalence; Risk Factors; Thrombosis | 2003 |
[Thrombotic, fibrinolytic and proliferative activities of pulmonary vascular bed in secondary pulmonary hypertension].
Topics: Adult; Antithrombin III; Cardiac Catheterization; Endothelium, Vascular; Female; Fibrinogen; Humans; Hypertension, Pulmonary; Hypertrophy, Left Ventricular; Male; Plasminogen; Plasminogen Inactivators; Platelet-Derived Growth Factor; Protein C; Pulmonary Circulation; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2005 |
[Cardiovascular risk factors in dialyzed patients].
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Blood Glucose; Blood Pressure; C-Reactive Protein; Calcium; Cardiovascular Diseases; Female; Fibrinogen; Hemodialysis, Home; Humans; Hyperlipidemias; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Myocardial Ischemia; Peritoneal Dialysis; Phosphates; Poland; Retrospective Studies; Risk Factors; Time Factors | 2004 |
[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].
Topics: Adult; Analysis of Variance; Case-Control Studies; Female; Fibrinogen; Fibrinolysis; Humans; Hyperlipidemias; Hypertension; Hypertrophy, Left Ventricular; Male; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Poland; Polymerase Chain Reaction; Polymorphism, Genetic; Risk Assessment; Risk Factors; Tissue Plasminogen Activator | 2005 |
Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study.
Topics: Black or African American; Brain Ischemia; Comorbidity; Coronary Disease; Diabetes Mellitus; Educational Status; Female; Fibrinogen; Follow-Up Studies; Humans; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Incidence; Intracranial Embolism; Leukocyte Count; Lipoprotein(a); Male; Maryland; Middle Aged; Minnesota; Mississippi; Multivariate Analysis; North Carolina; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; von Willebrand Factor; Waist-Hip Ratio; White People | 2006 |
Increased levels of inflammatory markers in hypertensives with target organ damage.
Topics: Aged; Biomarkers; C-Reactive Protein; Carotid Artery Diseases; Female; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Kidney Diseases; Male; Middle Aged; Multivariate Analysis; Reference Values; Tumor Necrosis Factor-alpha | 2006 |
Microalbuminuria is a marker of left ventricular hypertrophy but not hyperinsulinemia in nondiabetic atherosclerotic patients.
Topics: Administration, Oral; Aged; Albuminuria; Angiography; Arteriosclerosis; Blood Glucose; Blood Pressure; C-Peptide; Echocardiography; Fibrinogen; Glucose; Humans; Hyperinsulinism; Hypertrophy, Left Ventricular; Insulin; Lipids; Male; Middle Aged; Peripheral Vascular Diseases | 1993 |
Non-traditional risk factors for atherosclerosis in high risk children.
Topics: Adolescent; Adult; Arteriosclerosis; Autonomic Nervous System Diseases; Case-Control Studies; Child; Electrocardiography, Ambulatory; Female; Fibrinogen; Humans; Hyperinsulinism; Hyperlipoproteinemias; Hypertrophy, Left Ventricular; Insulin Resistance; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; Risk Factors; Thrombosis | 1996 |
Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy.
Topics: Adult; Aged; Black People; Blood Pressure; Blood Viscosity; Cross-Sectional Studies; Echocardiography; Endothelium, Vascular; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hematocrit; Hemoglobins; Hemorheology; Humans; Hypertension; Hypertrophy, Left Ventricular; India; Lipoprotein(a); Male; Middle Aged; Myocardial Ischemia; P-Selectin; Plasminogen Inactivators; Racial Groups; Risk Factors; Thrombosis; von Willebrand Factor; White People | 1997 |
Chlamydia pneumoniae antibodies in severe essential hypertension.
Topics: Antibodies, Bacterial; Chlamydophila pneumoniae; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Reference Values; von Willebrand Factor | 1998 |
Left ventricular hypertrophy and its regression: the prothrombic state in hypertension may be involved in its pathophysiology and altered by therapy.
Topics: Blood Viscosity; Fibrinogen; Humans; Hypertension; Hypertrophy, Left Ventricular; Thrombosis | 1999 |
Fibrinogen and preclinical echocardiographic target organ damage: the strong heart study.
Topics: Arteries; Echocardiography; Female; Fibrinogen; Hemodynamics; Humans; Hypertrophy, Left Ventricular; Kidney Diseases; Male; Middle Aged; Obesity; Prognosis; Risk Factors; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |